Insider transaction detail for Isa Odidi (IPCI)

495 views
439 views

Published on

Insider transaction detail for Isa Odidi, CEO of Intellipharmaceutics (IPCI)

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
495
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Insider transaction detail for Isa Odidi (IPCI)

  1. 1. Insider transaction detail - View details for insider 2012-05-14 16:26 ETTransactions sorted by : InsiderInsider family name : odidi ( Starts with )Given name : isa ( Starts with )Equity securities : American Depository Receipts, Common Shares, Convertible Preferred Shares, Exchangeable Shares, General Partnership Units, Instalment Receipts, Limited Partnership Units, MultipleVoting Shares, Non-Voting Shares, Participation Units, Preferred Shares, Special Shares, Subordinate Voting Shares, Trust Units, Units, OtherIssuer derivatives : Options, Rights, Special Warrants, Subscription Rights, Warrants, OtherInsider name: Odidi, IsaLegend: O - Original transaction, A - First amendment to transaction, A - Second amendment to transaction, AP - Amendment to paper filing, etc. Insiders Relationship to Issuer: 1 - Issuer, 2 - Subsidiary of Issuer, 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 8 - Deemed Insider - 6 Months before becoming Insider.Warning: The closing balance of the " equivalent number or value of underlying securities" reflects the" total number or value of underlying securities" to which the derivative contracts held by the insider relate. This disclosure does not mean and should not be taken to indicate that the underlying securities have, in fact, been acquired or disposed of by the insider.Transaction ID Date of Date of filing Ownership type Nature of Number or Unit price or Closing Insiders Conversion Date of Underlying security Equivalent Closing transaction YYYY-MM-DD (and registered transaction value acquired exercise balance calculated or exercise expiry or designation number or balance of YYYY-MM-DD holder, if or disposed of price balance price maturity value of equivalent applicable) YYYY-MM-DD underlying number or securities value of acquired or underlying disposed of securitiesIssuer name: INTELLIPHARMACEUTICS INTERNATIONAL INC.Insiders Relationship to Issuer: 4 - Director of Issuer, 5 - Senior Officer of IssuerCeased to be Insider: Not applicable -1-
  2. 2. Transaction ID Date of Date of filing Ownership type Nature of Number or Unit price or Closing Insiders Conversion Date of Underlying security Equivalent Closing transaction YYYY-MM-DD (and registered transaction value acquired exercise balance calculated or exercise expiry or designation number or balance of YYYY-MM-DD holder, if or disposed of price balance price maturity value of equivalent applicable) YYYY-MM-DD underlying number or securities value of acquired or underlying disposed of securitiesSecurity designation: Common Shares 2084951 2009-10-22 2012-05-14 Direct Ownership : 00 - Opening Balance-Initial SEDI Report 2084956 2012-05-10 2012-05-14 Direct Ownership : 10 - Acquisition or +1,000 1,000 1,000 disposition in the public marketSecurity designation: Options (Common Shares) 1506303 2009-10-22 2009-10-28 Direct Ownership : 00 - Opening 2,763,940 Common Shares 2,763,940 Balance-Initial SEDI Report 2032977 2012-02-17 2012-02-22 Direct Ownership : 50 - Grant of options +300,000 3.2700 3,063,940 2022-02-16 Common Shares +300,000 3,063,940 -2-

×